“…Since its Food and Drug Administration (FDA) approval in 2006, there has been an explosive development of medical lasers with different wavelengths (924, 968, 980, 1 064, 1 319, 1 320, 1 344, and 1 440 nm) that have eventually been employed for lipolysis and skin tightening (35)(36)(37)(38)(39) and mostly studies have supported the initial clinical observations in adiposity reduction, shorter recovery times, and improved skin retraction (40)(41)(42)(43). In this regard, the Lipolaser LPL9002™ device employed in this clinical case has the advantage of three lowpower cold lasers at wavelengths of 532, 650, and 980 nanometers, with no need for external cooling during the surgery, thus reducing the burn Panel 2.…”